SynopsisRopivacaine is the first pure levorotated long-acting amide local anesthetic, which has both anesthetic and analgesic effects. Large doses can produce surgical anesthesia, while small doses can produce sensory block (analgesia) with only limited non-progressiv.....
SynopsisThe global Dental Porcelain market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Dental Porcelain volume and value at the global level, r.....
SynopsisThe global Pulmonary Hypertension Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Hypertension Drug in various end use industries. The.....
SynopsisThe global Phosphor Screen Scanners market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Phosphor Screen Scanners in various end use industries. The expan.....
SynopsisThe global Glucosamine Sulfate Supplement market was valued at US$ 73 million in 2023 and is anticipated to reach US$ 104.5 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030. The market for Glucosamine Sulfate supplements is.....
SynopsisThe global Intraoral X-Ray Systems market was valued at US$ 1095.4 million in 2023 and is anticipated to reach US$ 1449.4 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030. According to our research, the global market for me.....
SynopsisAntiprotozoal agents (ATC code: ATC P01) is a class of pharmaceuticals used in treatment of protozoan infection. The global Antiprotozoal Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of.....
SynopsisAntiglaucoma drugs are drugs used to diagnose, cure, treat or prevent glaucoma diseases. The global Antiglaucoma Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast pe.....
SynopsisInterventional oncology devices are guided and monitored by imaging equipment such as digital subtraction angiography, CT, ultrasound, and magnetic resonance, and use puncture needles, catheters and other interventional devices to introduce specific devices th.....
SynopsisRanibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degenerat.....
